| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 378.23 KB | Adobe PDF | |||
| 1.74 KB | License |
Orientador(es)
Resumo(s)
Schizophrenia (SCZ) is a complex and multifactorial mental disorder. Currently, pharmacologic antipsychotic therapy (AP) focuses in SCZ symptoms minimization. AP has been associated with potentially adverse metabolic effects that may lead to an increased cardiovascular risk (CVR). To characterize SCZ patients of a psychosocial rehabilitation association (PRA) regarding antipsychotic therapy and sociodemographic, clinical, biochemical (total cholesterol, HDL-cholesterol, LDL-cholesterol, and triglycerides) and anthropometric parameters; To describe the AP prescription when observed changes in biochemical parameters.
Descrição
Palavras-chave
Contexto Educativo
Citação
Moura, L., Moreira, A., Ferreira, S., Moreira, T., Mota, S., Marques, A., & Amorim, M. (2015). Evaluation of disturbances in metabolism related to lipid profile in patients with schizophrenia. In R. A. Silva, P. Baylina, F. Q. Vieira, C. Barrias, M. Rubim, T. Coelho, C. Prudêncio, & Â. Jesus (Eds.), II Congresso Internacional da Saúde Gaia Porto: Livro de Resumos (1st ed., Vol. 1, pp. 129). Escola Superior de Tecnologia da Saúde do Instituto Politécnico do Porto.
Editora
Escola Superior de Tecnologia da Saúde do Instituto Politécnico do Porto